SAN DIEGO--(BUSINESS WIRE)--March 31, 2006--Cytori Therapeutics, Inc. (NASDAQ:CYTX) (Frankfurt:XMPA) announced today the appointment of an independent cardiovascular clinical advisory board comprised of internationally renowned experts in cardiology and cardiovascular imaging. This board will be instrumental in guiding the development of Cytori’s adipose-derived stem cell-based therapies for cardiovascular disease.
